Effects of acute agonist treatment on subcellular distribution of κ opioid receptor in rat spinal cord

Journal of Neuroscience Research

Volumn 87, Issue 7, 2009, Pages 1695-1702

  Wang, Yulin ^a   Xu, Wei ^a   Huang, Peng ^a   Chavkin, Charles ^b   Van Bockstaele, Elisabeth J ^c   Liu Chen, Lee Yuan ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Dorsal horn; Dynorphin; Electron microscopy; Internalization; U50,488H

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DYNORPHIN A; KAPPA OPIATE RECEPTOR; OPIATE AGONIST; POLYCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CELL MEMBRANE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITE; DRUG MECHANISM; ELECTRON MICROSCOPY; IMMUNOELECTRON MICROSCOPY; IMMUNOREACTIVITY; LUMBAR SPINAL CORD; MALE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR OCCUPANCY; RECEPTOR UPREGULATION; SILVER STAINING; SPINAL CORD DORSAL HORN;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALYSIS OF VARIANCE; ANIMALS; CATHETERIZATION; CELL LINE; CELL MEMBRANE; DYNORPHINS; FLUORESCENCE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, SPINAL; LUMBAR VERTEBRAE; MALE; MICROSCOPY, IMMUNOELECTRON; POSTERIOR HORN CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SPINAL CORD;

EID: 65849295964     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21971     Document Type: Article

References (37)

1. Arvidsson U, Riedl M, Chakrabarti S, Vulchanova L, Lee JH, Nakano AH, Lin X, Loh HH, Law P-Y, Wessendorf MW, Elde R. 1995. The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids. Proc Natl Acad Sci U S A 92:5062-5066.
2. Besse D, Lombard MC, Zajac JM, Roques BP, Besson JM. 1990. Preand postsynaptic distribution of mu, delta and kappa opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res 521:15-22.
3. Cahill CM, McClellan KA, Morinville A, Hoffert C, Hubatsch D, O'Donnell D, Beaudet A. 2001a. Immunohistochemical distribution of delta opioid receptors in the rat central nervous system: evidence for somatodendritic labeling and antigen-specific cellular compartmentalization. J Comp Neurol 440:65-84.
4. Cahill CM, Morinville A, Lee MC, Vincent JP, Collier B, Beaudet A. 2001b. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J Neurosci 21:7598-7607.
5. Cahill CM, Morinville A, Hoffert C, O'Donnell D, Beaudet A. 2003. Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: implications for pain control. Pain 101:199-208.
6. Chen Y, Chen C, Wang Y, Liu-Chen LY. 2006. Ligands regulate cell surface level of the human j opioid receptor by activation-induced down-regulation and pharmacological chaperone-mediated enhancement: differential effects of nonpeptide and peptide agonists. J Pharmacol Exp Ther 319:765-775.
7. Dawson-Basoa ME, Gintzler AR. 1996. Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms. Pain 64:169-177.
8. Drake CT, Patterson TA, Simmons ML, Chavkin C, Milner TA. 1996. Kappa opioid receptor-like immunoreactivity in guinea pig brain: ultrastructural localization in presynaptic terminals in hippocampal formation. J Comp Neurol 370:377-395.
9. Eisinger DA, Schulz R. 2004. Extracellular signal-regulated kinase/ mitogen-activated protein kinases block internalization of delta-opioid receptors. J Pharmacol Exp Ther 309:776-785.
10. Harris JA, Drake CT. 2001. Kappa opioid receptor density is consistent along the rostrocaudal axis of the female rat spinal cord. Brain Res 905:236-239.
11. Harris JA, Chang PC, Drake CT. 2004. Kappa opioid receptors in rat spinal cord: sex-linked distribution differences. Neuroscience 124:879-890.
12. Herman BH, Goldstein A. 1985. Antinociception and paralysis induced by intrathecal dynorphin A. J Pharmacol Exp Ther 232:27-32.
13. Jordan BA, Cvejic S, Devi LA. 2000. Kappa opioid receptor endocytosis by dynorphin peptides. DNA Cell Biol 19:19-27.
14. Li J, Li J-G, Chen C, Zhang F, Liu-Chen L-Y. 2002. Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)- cyclohexyl] benzeneacetamide-induced desensitization and phosphorylation between human and rat j-opioid receptors expressed in Chinese hamster ovary cells. Mol Pharmacol 61:73-84.
15. Li J-G, Luo LY, Krupnick JG, Benovic JL, Liu-Chen L-Y. 1999. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation. J Biol Chem 274:12087-12094.
16. Liu-Chen L-Y. 2004. Agonist-induced regulation and trafficking of kappa opioid receptors. Life Sci 75:511-536.
17. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ. 1988. Anatomy of CNS opioid receptors. Trends Neurosci 11:308-314.
18. Mansour A, Burke S, Pavlic RJ, Akil H, Watson SJ. 1996. Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary. Neuroscience 71:671-690.
19. McLaughlin JP, Marton-Popovici M, Chavkin C. 2003a. Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23:5674-5683.
20. McLaughlin JP, Xu M, Mackie K, Chavkin C. 2003b. Phosphorylation of a carboxy-terminal serine within the kappa opioid receptor produces desensitization and internalization. J Biol Chem 278:34631-34640.
21. Miaskowski C, Taiwo YO, Levine JD. 1990. Kappa- and delta-opioid agonists synergize to produce potent analgesia. Brain Res 509:165-168.
22. Millan MJ, Czlonkowski A, Lipkowski A, Herz A. 1989. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action. J Pharmacol Exp Ther 251:342-350.
23. Morris BJ, Herz A. 1987. Distinct distribution of opioid receptor types in rat lumbar spinal cord. Naunyn Schmiedebergs Arch Pharmacol 336: 240-243.
24. Pelissier T, Paeile C, Soto-Moyano R, Saavedra H, Hernandez A. 1990. Analgesia produced by intrathecal administration of the kappa opioid agonist, U-50,488H, on formalin-evoked cutaneous pain in the rat. Eur J Pharmacol 190:287-293.
25. Peters A, Palay SL, Webster Hd. 1991. The fine structure of the nervous system, neurons and their supporting cells. New York: Oxford University Press.
26. Przewlocki R, Shearman GT, Herz A. 1983. Mixed opioid/nonopioid effects of dynorphin and dynorphin related peptides after their intrathecal injection in rats. Neuropeptides 3:233-240.
27. Schepers RJ, Mahoney JL, Shippenberg TS. 2007. Inflammation-induced changes in rostral ventromedial medulla mu and kappa opioid receptor mediated antinociception. Pain (in press).
28. Scherrer G, Tryoen-Toth P, Filliol D, Matifas A, Laustriat D, Cao YQ, Basbaum AI, Dierich A, Vonesh JL, Gaveriaux-Ruff C, Kieffer BL. 2006. Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc Natl Acad Sci U S A 103:9691-9696.
29. Schulz R, Wehmeyer A, Schulz K. 2002. Visualizing preference of G protein-coupled receptor kinase 3 for the process of kappa-opioid receptor sequestration. Mol Pharmacol 61:1444-1452.
30. Shuster SJ, Riedl M, Li X, Vulchanova L, Elde R. 1999. Stimulus-dependent translocation of kappa opioid receptors to the plasma membrane. J Neurosci 19:2658-2664.
31. Spampinato S, Candeletti S. 1985. Characterization of dynorphin A-induced antinociception at spinal level. Eur J Pharmacol 110:21-30.
32. Stroh T, Jackson AC, Sarret P, Dal Farra C, Vincent JP, Kreienkamp HJ, Mazella J, Beaudet A. 2000. Intracellular dynamics of sst5 receptors in transfected COS-7 cells: maintenance of cell surface receptors during ligand-induced endocytosis. Endocrinology 141:354-365.
33. Van Bockstaele EJ, Commons KG. 2001. Internalization of mu-opioid receptors produced by etorphine in the rat locus coeruleus. Neuroscience 108:467-477.
34. Vanderah TW, Laughlin T, Lashbrook JM, Nichols ML, Wilcox GL, Ossipov MH, Malan TP Jr, Porreca F. 1996. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain 68:275-281.
35. Wang H, Pickel VM. 2001. Preferential cytoplasmic localization of delta-opioid receptors in rat striatal patches: comparison with plasmalemmal mu-opioid receptors. J Neurosci 21:3242-3250.
36. Wood PL, Rackham A, Richard J. 1981. Spinal analgesia: comparison of the mu agonist morphine and the kappa agonist ethylketazocine. Life Sci 28:2119-2125.
37. Zhang F, Li J, Li J-G, Liu-Chen L-Y. 2002. (-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl] benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: Structural basis for the differential regulation. J Pharmacol Exp Ther 302:1184-1192.